Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials

European Journal of Cancer Care

Volumn 24, Issue 1, 2015, Pages 133-141

  Godskesen, T ^a   Hansson, M G ^b   Nygren, P ^c   Nordin, K ^a,d   Kihlbom, U ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Center for Research Ethics and Bioethics   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cancer; Clinical trials

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALTRUISM; COMPREHENSION; FEMALE; HOPE; HUMAN; MALE; MIDDLE AGED; MOTIVATION; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; SWEDEN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALTRUISM; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III AS TOPIC; COMPREHENSION; FEMALE; HOPE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SATISFACTION; SURVEYS AND QUESTIONNAIRES; SWEDEN;

EID: 84919847114     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/ecc.12184     Document Type: Article

References (24)

1. Appelbaum P.S., Roth L.H. & Lidz C. (1982) The therapeutic misconception: informed consent in psychiatric research. International Journal of Law and Psychiatry 5, 319-329.
2. Appelbaum P.S., Anatchkova M., Albert K., Dunn L.B. & Lidz C.W. (2012) Therapeutic misconception in research subjects: development and validation of a measure. Clinical Trials 9, 748-761.
3. Beauchamp T.L. & Childress J.F. (2009) Principles of Biomedical Ethics. Oxford University Press, New York, NY, USA.
4. Biedrzycki B.A. (2010) Decision making for cancer clinical trial participation: a systematic review. Oncology Nursing Forum 37, E387-E399.
5. Biedrzycki B.A. (2011) Factors and outcomes of decision making for cancer clinical trial participation. Oncology Nursing Forum 38, 542-552.
6. Coyne C.A., Xu R., Raich P., Plomer K., Dignan M., Wenzel L.B., Fairclough D., Habermann T., Schnell L., Quella S., Cella D. & Eastern Cooperative Oncology G. (2003) Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 21, 836-842.
7. Ellis P.M., Butow P.N., Tattersall M.H., Dunn S.M. & Houssami N. (2001) Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. Journal of Clinical Oncology 19, 3554-3561.
8. Fisher B. (1991) On clinical trial participation. Journal of Clinical Oncology 9, 1927-1930.
9. Garcea G., Lloyd T., Steward W.P., Dennison A.R. & Berry D.P. (2005) Differences in attitudes between patients with primary colorectal cancer and patients with secondary colorectal cancer: is it reflected in their willingness to participate in drug trials? European Journal of Cancer Care 14, 166-170.
10. Gerhard T. (2008) Bias: considerations for research practice. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists 65, 2159-2168.
11. Hutchison C., Cowan C. & Paul J. (2007) Patient understanding of research: developing and testing of a new questionnaire. European Journal of Cancer Care 16, 187-195, quiz 195-186.
12. Kim S.Y.H., Millard R.W., Nisbet P., Cox C. & Caine E.D. (2004) Potential research participants' views regarding researcher and institutional financial conflicts of interest. Journal of Medical Ethics 30, 73-79.
13. Levine R.J. (1993) Ethics of clinical trials. Do they help the patient? Cancer 72, 2805-2810.
14. Mancini J., Genre D., Dalenc F., Ferrero J.M., Kerbrat P., Martin A.L., Roche H., Maylevin F., Tarpin C., Viens P., Gamet C. & Julian-Reynier C. (2012) Patients' regrets after participating in a randomized controlled trials depended on their involvement in the decision making. Journal of Clinical Epidemiology 65, 635-642.
15. McCann S.K., Campbell M.K. & Entwistle V.A. (2010) Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials 11, 31. [Electronic Resource].
16. Medicine I.O. (2002) Responsible Research: A Systems Approach to Protecting Research Participants. The National Academies Press, Washington, DC, USA.
17. Murthy V.H., Krumholz H.M. & Gross C.P. (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA: The Journal of the American Medical Association 291, 2720-2726.
18. NBAC. (2001). Ethical and policy issues in research involving human participants. Available at: http://bioethics.georgetown.edu/nbac/human/oversumm.pdf (cited 2001).
19. Rosenberg W. & Donald A. (1995) Evidence based medicine: an approach to clinical problem-solving. BMJ (Clinical Research Ed.) 310, 1122-1126.
20. Shah J.Y., Phadtare A., Rajgor D., Vaghasia M., Pradhan S., Zelko H. & Pietrobon R. (2010) What leads Indians to participate in clinical trials? A meta-analysis of qualitative studies. PLoS ONE 5, e10730.
21. Socialstyrelsen T.N.B.O.H.a.W. (2011) Quality and Efficiency in Swedish Cancer Care - Regional comparisons 2011 (ed 2009:11, S.).
22. Streiner D.L. & Norman G.R. (2008) Health Measurement Scales. Oxford University Press, New York, NY, USA.
23. Stryker J.E., Wray R.J., Emmons K.M., Winer E. & Demetri G. (2006) Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Patient Education and Counseling 63, 104-109.
24. Verheggen F.W., Nieman F.H., Reerink E. & Kok G.J. (1998) Patient satisfaction with clinical trial participation. International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care/ISQua 10, 319-330.